Advancing Hydrocephalus Research and Treatment Options: Non-Invasive Therapy Research Workshop
More than 75 experts in hydrocephalus gathered in Cincinnati, OH for the 2024 Research Workshop focused on finding ways to better treat hydrocephalus, aiming to make treatments safer and less invasive.
Read More >
Announcing the 2023 Hydrocephalus Association Innovator Award Recipients
In medical research, innovation is the catalyst for change, the driving force behind medical breakthroughs…
Read More >
Anuncia Medical, Inc., Announces Published Data with Clinical Outcomes Using the ReFlow™ Ventricular System In-Line with Hydrocephalus Shunts
Anuncia Medical, Inc., a company advancing innovations for cerebrospinal fluid (CSF) management systems and neurocritical care haspublished an article in the journal Pediatric Neurosurgery reporting the use of the ReFlow™ Ventricular System with Hydrocephalus shunts in patients suffering from chronic shunt occlusions.
Read More >
Study Finds ShuntCheck is an Effective Aid for Emergency Room Doctors
Study Finds ShuntCheck is an effective aid for emergency room doctors in determining the need…
Read More >
Announcing the Hydrocepahlus Association’s 2022 Innovator Award Recipients
An unprecedented 10 Innovator Awards go out to scientists for their exciting research. Despite…
Read More >
Five Scientists Awarded HA Grants for Their Bold and Innovative Work
Announcing our 2021 Innovator Award recipients! These brilliant scientists are exploring new ideas about why hydrocephalus develops and testing new treatments to improve long term outcomes.
Read More >
Grey Matter Brain Damage
This blog explains the difference between white and grey matter injuries and their effects on the brain.
Read More >
TECHNOLOGY UPDATE: Rhaeos, Inc. Awarded NIH Grant to Advance Development of FlowSense Wireless Sensor
Rhaeos, Inc. was awarded an NIH grant to advance their development of wearable sensors to detect failed shunts in patients with hydrocephalus.
Read More >
Research 101: Generalizability
The concept of Generalizability in research studies is especially important for individuals living with hydrocephalus because there are so many different causes.
Read More >
Announcement About Anuncia ReFlowTM System Mini
Earlier this year, Anuncia Inc., a medical device company focused on the development of treatment devices for hydrocephalus and other cerebrospinal fluid (CSF) disorders, announced that the ReFlowTM System Mini received the U.S Food and Drug Administration (FDA) Breakthrough Device Designation. The ReFlowTM System Mini is the next generation version of the commercial ReFlowTM Ventricular System.
Read More >
In the NICU: Preparing Families for Life with Hydrocephalus
A recent study explored how neonatal intensive care units (NICUs) can better prepare families that receive a diagnosis of posthemorrhagic hydrocephalus of prematurity (PHHP).
Read More >
Innovator Award Series: Get to Know Dr. Aditya S. Pandey
In this installment of our Meet the Innovator Award Grantees Blog Series, we interviewed Dr. Aditya S. Pandey, one of four scientists who received a 2020 Innovator Award. Dr. Pandey’s team is testing the use of acetazolamide (Diamox) directly into the ventricles to determine if it can prevent hydrocephalus.
Read More >